Decamethonium Bromide is a depolarising neuromuscular blocking agent that acts as a nicotinic acetylcholine receptor agonist at the neuromuscular junction, used historically as a surgical muscle relaxant and now primarily as a pharmacological research tool. Simson Pharma's Decamethonium Bromide reference standard supports research and legacy analytical applications.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Decamethonium bromide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.